Search Results

Investigation Report on China's Insulin Aspart Market, 2018-2022

• Source: M2PressWIRE. 11/02/2018.

Record details

China's Insulin Aspart Market 2013-2022: Disease Overview, Sales, Prices, Progress & Market Prospects

• Authors : PR Newswire

Subjects: Ireland; United Kingdom; United States of America

• Source: PR Newswire US. 11/02/2018.

Record details

China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk

• Source: M2PressWIRE. 08/28/2015.

Record details

Investigation Report on China's Insulin Aspart Market to 2018

• Source: M2PressWIRE. 03/14/2014.

Record details

LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM

• Authors : PR Newswire

Subjects: Pennsylvania

• Source: PR Newswire US. 11/07/2022.

Record details

Faster-acting insulin aspart showed a statistically significant reduction in HbA(1c) in type 1 diabetes and a comparable HbA(1c) reduction in type 2 diabetes versus NovoRapid® (insulin aspart)

• Authors : Canada Newswire

Subjects: Louisiana

• Source: Canada Newswire. 06/13/2016.

Record details

Novo Nordisk Submits NDA to FDA for Faster-Acting Insulin Aspart for Treatment of Type 1, 2 Diabetes.

• Authors : Charles Gross

• Source: Benzinga. 12/09/2015.

Record details

China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk

• Authors : PR Newswire

Subjects: Ireland; United Kingdom; United States of America

• Source: PR Newswire US. 08/28/2015.

Record details

Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoLog® (insulin aspart [rDNA origin] injection)

• Authors : PR Newswire

Subjects: United States of America

• Source: PR Newswire US. 06/13/2016.

Record details

Novo Nordisk files for regulatory approval of "faster-acting insulin aspart" in the U.S.

• Authors : PR Newswire

Subjects: New Jersey

• Source: PR Newswire US. 12/09/2015.

Record details